首页> 外文期刊>Nature >Rab5 is necessary for the biogenesis of the endolysosomal system in vivo
【24h】

Rab5 is necessary for the biogenesis of the endolysosomal system in vivo

机译:Rab5对于体内溶酶体系统的生物发生是必需的

获取原文
获取原文并翻译 | 示例
       

摘要

An outstanding question is how cells control the number and size of membrane organelles. The small GTPase Rab5 has been proposed to be a master regulator of endosome biogenesis. Here, to test this hypothesis, we developed a mathematical model of endosome dependency on Rab5 and validated it by titrating down all three Rab5 isoforms in adult mouse liver using state-of-the-art RNA interference technology. Unexpectedly, the endocytic system was resilient to depletion of Rab5 and collapsed only when Rab5 decreased to a critical level. Loss of Rab5 below this threshold caused a marked reduction in the number of early endosomes, late endosomes and lysosomes, associated with a block of low-density lipoprotein endocytosis. Loss of endosomes caused failure to deliver apical proteins to the bile canaliculi, suggesting a requirement for polarized cargo sorting. Our results demonstrate for the first time, to our knowledge, the role of Rab5 as an endosome organizer in vivo and reveal the resilience mechanisms of the endocytic system.
机译:一个悬而未决的问题是细胞如何控制膜细胞器的数量和大小。有人提出小GTPase Rab5是内体生物发生的主要调控因子。在这里,为了检验这一假设,我们建立了核糖体对Rab5依赖性的数学模型,并通过使用最新的RNA干扰技术滴定了成年小鼠肝脏中的所有三种Rab5亚型,对其进行了验证。出乎意料的是,内吞系统对Rab5的耗竭具有复原力,并且仅在Rab5降至临界水平时才崩溃。低于该阈值的Rab5的损失导致早期内体,晚期内体和溶酶体的数量显着减少,与低密度脂蛋白内吞作用有关。内体的损失导致无法将顶端蛋白传递至胆小管,提示需要极化货物分选。据我们所知,我们的结果首次证明了Rab5作为体内内体组织者的作用,并揭示了内吞系统的弹性机制。

著录项

  • 来源
    《Nature》 |2012年第7399期|p.465-470|共6页
  • 作者单位

    Max Planck Institute of Molecular Cell Biology and Genetics, 01307 Dresden, Germany;

    Max Planck Institute of Molecular Cell Biology and Genetics, 01307 Dresden, Germany;

    Koch I nstitute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA;

    Max Planck Institute of Molecular Cell Biology and Genetics, 01307 Dresden, Germany;

    Max Planck Institute of Molecular Cell Biology and Genetics, 01307 Dresden, Germany;

    Max Planck Institute of Molecular Cell Biology and Genetics, 01307 Dresden, Germany;

    Alnylam Pharmaceuticals, Inc., Cambridge, Massachusetts 02142, USA;

    Alnylam Pharmaceuticals, Inc., Cambridge, Massachusetts 02142, USA;

    Alnylam Pharmaceuticals, Inc., Cambridge, Massachusetts 02142, USA;

    Cardiovascular Research Center and Center for Human Genetic Research, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA;

    Max Planck Institute of Molecular Cell Biology and Genetics, 01307 Dresden, Germany;

    Leibniz Research Centre for Working Environmentand Human Factors (IfADo), 44139 Dortmund, Germany;

    Max Planck Institute of Molecular Cell Biology and Genetics, 01307 Dresden, Germany,Belozersky Institute of Physico-Chemical Biology, Moscow State University, 119899, Moscow, Russia;

    Koch I nstitute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA,Alnylam Pharmaceuticals, Inc., Cambridge, Massachusetts 02142, USA;

    Max Planck Institute of Molecular Cell Biology and Genetics, 01307 Dresden, Germany;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号